2025 Bone and Soft Tissue Multidisciplinary Tumor Board

Occurs every 2 weeks on Tuesday starting on 1/7/2025 at 4:00 PM
Tuesday, January 7, 2025, 4:00 PM - 5:00 PM, Cedars-Sinai Medical Center, Los Angeles, CA


Bone and Soft Tissue Multidisciplinary Tumor Board is a monthly series that will update clinicians on many common and emerging issues encountered in practice related to bone and soft tissue tumors, including information that supports optimal diagnostic and therapeutic decision making.

1. Recognize new and rapidly evolving standards of care for bone and soft tissue tumors that can be applied in practice.
2. Identify the radiologic, clinical, and pathologic features of various bone and soft tissue tumors.
3. Distinguish key features in diagnosis and treatment of selected bone and soft tissue tumors.

In support of improving patient care, Cedars-Sinai is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

AMA Credit Designation Statement
Cedars-Sinai designates this Live Activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Non-Physician AMA Attendance
Attendance credit will be provided to other healthcare professionals upon the fulfillment of attendance requirements. Participants should ensure in advance that their credentialing or licensing organization accepts AMA PRA Category 1 Credits™.  

AMA PRA Category 1 Credit(s)™ (MD, DO) (1.00 hours), Non-Physician AMA Attendance (1.00 hours)

Mitigation of Relevant Financial Relationships

Cedars-Sinai adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Date	Empty Column	Title
		No activities are currently published for this month.
No upcoming dates have been setup.